Compare Wells Fargo & Co (WFC) vs Health Care Select Sector SPDR Fund (XLV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Wells Fargo & Co vs Health Care Select Sector SPDR Fund — how do they compare? Wells Fargo & Co trades at $90 (market cap $271.16B), while Health Care Select Sector SPDR Fund trades at $167.05. The key difference: Wells Fargo & Co pays a 2.23% dividend while Health Care Select Sector SPDR Fund pays none. Which is the better fit depends on your goals.
| WFC | XLV | |
|---|---|---|
Market Cap | $271.16B | — |
Sector | Financials | — |
52-Week High | $96.40 | $175.68 |
52-Week Low | $73.42 | $134.13 |
Dividend Yield | 2.23% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Wells Fargo (WFC) trades at $87.98, down 2.21% on the day, amid mixed earnings performance but strong profitability trends. The stock shows a bullish technical signal with support near $87 and resistance at $89, while fundamentals reveal a P/E of 12.78 and net income margin of 25.97% for 2025. Recent news highlights CEO Charlie Scharf's focus on dealmaking and a push to expand wealth management, with institutional buying activity noted in August 2026 filings.
Outlook remains cautiously optimistic with a consensus price target of $97.64, implying 11% upside, supported by improved return on tangible common equity and dividend payments. Risks include volatile cash flows, regulatory scrutiny, and interest rate sensitivity. Analyst consensus is balanced with 45% buy ratings, but recent earnings misses warrant monitoring execution against guidance.
XLV trades at $167.16, down 2.5% amid testing key support levels, with technical indicators showing mixed signals between bullish moving averages and bearish oscillators. The healthcare ETF maintains defensive appeal with upcoming dividend payments and sector rotation benefits during potential Fed tightening. Recent options activity shows increased put volume, suggesting some near-term caution among traders.
Healthcare sector strength and defensive positioning support XLV's long-term outlook, though near-term technical weakness and sector-specific headwinds from failed drug trials present risks. The ETF's low expense ratio and diversified healthcare exposure provide stability, with earnings momentum and FDA approvals driving fundamental strength.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Wells Fargo & Co
Wells Fargo is one of the largest banks in the United States, with approximately $1.9 trillion in balance sheet assets. The company is split into four primary segments: consumer banking, commercial banking, corporate and investment banking, and wealth and investment management. It is almost entirely focused on the U.S.
Read more on WFC →About Health Care Select Sector SPDR Fund
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
Read more on XLV →
